Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
JUNO

Juno Therapeutics

$30.39

0.51 (1.71%)

08:06
08/08/17
08/08
08:06
08/08/17
08:06
Hot Stocks
Juno Therapeutics executives under investigation »

Shareholder and consumer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

JUNO

Juno Therapeutics

$29.07

0.09 (0.31%)

17:30
08/03/17
08/03
17:30
08/03/17
17:30
Hot Stocks
Breaking Hot Stocks news story on Juno Therapeutics »

Juno backs FY17 cash burn…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 15

    Aug

JUNO

Juno Therapeutics

$29.07

0.09 (0.31%)

17:29
08/03/17
08/03
17:29
08/03/17
17:29
Earnings
Juno Therapeutics reports Q2 adjusted EPS (74c), consensus (72c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 15

    Aug

Over a month ago
A

Agilent

$61.21

-0.34 (-0.55%)

, JUNO

Juno Therapeutics

$27.62

0.31 (1.14%)

18:48
07/18/17
07/18
18:48
07/18/17
18:48
Hot Stocks
Agilent names Juno CEO Bishop to board of directors »

Agilent (A) announced…

A

Agilent

$61.21

-0.34 (-0.55%)

JUNO

Juno Therapeutics

$27.62

0.31 (1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 15

    Aug

JUNO

Juno Therapeutics

$28.06

0.03 (0.11%)

09:10
07/14/17
07/14
09:10
07/14/17
09:10
Syndicate
Juno Therapeutics 7M share Block Trade priced at $27.40 »

Morgan Stanley acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$82.55

-0.66 (-0.79%)

, KITE

Kite Pharma

$103.36

-1.29 (-1.23%)

18:12
07/13/17
07/13
18:12
07/13/17
18:12
Periodicals
Three drugmakers may capitalize on Novartis' cancer therapy, Barron's reports »

Novartis' (NVS)…

NVS

Novartis

$82.55

-0.66 (-0.79%)

KITE

Kite Pharma

$103.36

-1.29 (-1.23%)

JUNO

Juno Therapeutics

$28.06

0.03 (0.11%)

BLUE

bluebird bio

$96.00

0.3 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 18

    Jul

  • 29

    Nov

KITE

Kite Pharma

$104.65

0.95 (0.92%)

, JUNO

Juno Therapeutics

$28.03

0.14 (0.50%)

05:55
07/13/17
07/13
05:55
07/13/17
05:55
Recommendations
Kite Pharma, Juno Therapeutics, Novartis analyst commentary at Citi »

Novartis vote bodes well…

KITE

Kite Pharma

$104.65

0.95 (0.92%)

JUNO

Juno Therapeutics

$28.03

0.14 (0.50%)

NVS

Novartis

$83.21

1.22 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 18

    Jul

  • 29

    Nov

JUNO

Juno Therapeutics

$29.70

0.7 (2.41%)

12:05
06/27/17
06/27
12:05
06/27/17
12:05
Options
Juno Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$23.29

0.77 (3.42%)

04:55
06/19/17
06/19
04:55
06/19/17
04:55
Conference/Events
Juno Therapeutics management to meet with Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

JUNO

Juno Therapeutics

$23.29

0.77 (3.42%)

14:30
06/18/17
06/18
14:30
06/18/17
14:30
Hot Stocks
Juno Therapeutics reports data from 'TRANSCEND' trial of JCAR017 »

Juno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.